Cargando…

DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) is a rapidly progressive cancer that often develops resistance against DNA damage inducers, such as radiotherapy and chemotherapy, which are still the standard of care regimens for this tumor. Thus, the identification of biomarkers capable of monitoring the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pomella, Silvia, Cassandri, Matteo, Melaiu, Ombretta, Marampon, Francesco, Gargari, Marco, Campanella, Vincenzo, Rota, Rossella, Barillari, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916929/ https://www.ncbi.nlm.nih.gov/pubmed/36768994 http://dx.doi.org/10.3390/ijms24032673

Ejemplares similares

The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview
por: Barillari, Giovanni, et al.
Publicado: (2022)

New Insights on the Nuclear Functions and Targeting of FAK in Cancer
por: Pomella, Silvia, et al.
Publicado: (2022)

Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2022)

Radioresistance in rhabdomyosarcomas: Much more than a question of dose
por: Camero, Simona, et al.
Publicado: (2022)

Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation
por: Perrone, Clara, et al.
Publicado: (2023)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
por: Camero, Simona, et al.
Publicado: (2021)

CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
por: Cassandri, Matteo, et al.
Publicado: (2020)

MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells
por: Cassandri, Matteo, et al.
Publicado: (2021)

The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
por: Pomella, Silvia, et al.
Publicado: (2020)

The botanical drug PBI-05204, a supercritical CO(2) extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
por: Vaccaro, Sara, et al.
Publicado: (2022)

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies
por: Melaiu, Ombretta, et al.
Publicado: (2023)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
por: Pesce, Silvia, et al.
Publicado: (2023)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors
por: Codenotti, Silvia, et al.
Publicado: (2022)

Impact of Natural Occurring ERAP1 Single Nucleotide Polymorphisms within miRNA-Binding Sites on HCMV Infection
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
por: Lucarini, Valeria, et al.
Publicado: (2021)

Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor
por: Tiago, Tatiana, et al.
Publicado: (2021)

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?
por: D’Amico, Silvia, et al.
Publicado: (2021)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
por: D’Amico, Silvia, et al.
Publicado: (2022)

Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance
por: Vincent-Chong, Vui King, et al.
Publicado: (2017)

Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas
por: Banerjee, Sagarika, et al.
Publicado: (2017)

Quantification of the Immune Content in Neuroblastoma: Deep Learning and Topological Data Analysis in Digital Pathology
por: Bussola, Nicole, et al.
Publicado: (2021)

The ZNF750–RAC1 axis as potential prognostic factor for breast cancer
por: Butera, Alessio, et al.
Publicado: (2020)

Oral Lichen Planus and Oral Squamous Cell Carcinoma share key oncogenic signatures
por: de Lanna, Cristóvão Antunes, et al.
Publicado: (2022)

Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021)

Epigenetic remodelling in human hepatocellular carcinoma
por: Braghini, Maria Rita, et al.
Publicado: (2022)

Resistance/Response Molecular Signature for Oral Tongue Squamous Cell Carcinoma
por: Suresh, Amritha, et al.
Publicado: (2012)

Prognostic signature related to the immune environment of oral squamous cell carcinoma
por: Hua, Yingjie, et al.
Publicado: (2022)

Mast cell marker gene signature in head and neck squamous cell carcinoma
por: Cai, Zhimou, et al.
Publicado: (2022)

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
por: De Felice, Francesca, et al.
Publicado: (2016)

Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021)

Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity
por: D’Amico, Silvia, et al.
Publicado: (2023)

Telomerase in saliva: An assistant marker for oral squamous cell carcinoma
por: Samadi, Fahad Mansoor, et al.
Publicado: (2019)

Role of Inflammatory Markers in Prognosis of Oral Squamous Cell Carcinoma
por: Dantas, Thinali Sousa, et al.
Publicado: (2019)

Secreted protein markers in oral squamous cell carcinoma (OSCC)
por: Mumtaz, Madiha, et al.
Publicado: (2022)

Glut1 and Glut3 as Potential Prognostic Markers for Oral Squamous Cell Carcinoma
por: Ayala, Fernanda Rocha Rojas, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kbi9pmom3mejprdgja9gv1p2f8